Dicarboxylic acids as markers of fatty acid peroxidation in diabetes.
Increased urinary excretion of dicarboxylic acids (DAs) has been well known in patients with diabetic ketoacidosis (DKA). It was known that small amounts of such DAs were also detected in urine from healthy humans. Upon chemical, radiation-induced or enzymatic oxidation, cis-polyunsaturated fatty acids (PUFA) have previously been shown to generate saturated short- and medium-chain length DAs. In diabetes, it was confirmed that the imbalance between the generation of free radicals and antioxidant defense systems increases oxidative stress and leads to the damage of lipid, which contains PUFA. Some peroxidation products of PUFA, such as malondialdehyde and conjugated diene, are generally known to be elevated in patients with diabetes. The present study was undertaken to determine if urinary excretion of DAs is elevated in diabetic patients without DKA. Urine samples from ten non-ketoacidotic patients with type 2 diabetes and ten healthy subjects were examined for DAs by combined gas chromatography and mass spectrometry with selected ion monitoring. The diabetic subjects had significantly (Psebacic acid. Being stable and easily detectable compounds, DAs may be considered potential markers of oxidative attack on PUFA in diabetes.
Inouye
M
M
Department of Internal Medicine, Hyogo Rehabilitation Center Hospital, Akebono-cho 1070, Nishi-ku, Kobe, Japan.
Mio
T
T
Sumino
K
K
D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000652:urine; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism* / Q000652:urine; D003998:Dicarboxylic Acids / Q000652:urine*; D004355:Drug Stability; D005227:Fatty Acids / Q000378:metabolism*; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D008297:Male; D008875:Middle Aged; D010545:Peroxides / Q000378:metabolism*; D012016:Reference Values; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D015415:Biomarkers; D003998:Dicarboxylic Acids; D005227:Fatty Acids; D010545:Peroxides